loader

AbbVie Inc.

NYSE:ABBV:US
Featured Articles and Interviews

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

5 Biggest Pharmaceutical ETFs in 2025

What is In-Licensing?

Press Releases

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award Contest to Support Their Professional Goals

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Interactive Chart

×